Publication|Articles|September 13, 2024
- Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Advertisement
Learn about a treatment for pulmonary arterial hypertension.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rural health is ailing. Is $50 billion enough to heal it?
2
Recombinant shingles vaccine linked to lower cardiovascular disease risk
3
Real-World Safety Experience and Clinical Takeaways from the BE BOLD Trial
4
Medicare Part D redesign reshapes market
5









